Your browser doesn't support javascript.
loading
Chimeric antigen receptor (CAR) T cells for the treatment of a kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD).
Kline, Kathryn; Chen, Wengen; Kallen, Michael E; Koka, Rima; Omili, Destiny; Fan, Xiaoxuan; Iraguha, Thierry; Gebru, Etse; Dishanthan, Nishanthini; Baker, Jillian M; Dietze, Kenneth A; Yared, Jean A; Hankey, Kim; Dahiya, Saurabh; Niederhaus, Silke V; Dunleavy, Kieron; Hardy, Nancy M; Luetkens, Tim; Rapoport, Aaron P; Atanackovic, Djordje.
Afiliación
  • Kline K; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
  • Chen W; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Kallen ME; Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Koka R; Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Omili D; Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Fan X; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
  • Iraguha T; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
  • Gebru E; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
  • Dishanthan N; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD, USA.
  • Baker JM; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
  • Dietze KA; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
  • Yared JA; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
  • Hankey K; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
  • Dahiya S; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
  • Niederhaus SV; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
  • Dunleavy K; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD, USA.
  • Hardy NM; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD, USA.
  • Luetkens T; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
  • Rapoport AP; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Atanackovic D; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
Hum Vaccin Immunother ; 19(2): 2216116, 2023 08 01.
Article en En | MEDLINE | ID: mdl-37278257
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Órganos / Trasplante de Riñón / Receptores Quiméricos de Antígenos / Trastornos Linfoproliferativos Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Revista: Hum Vaccin Immunother Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Órganos / Trasplante de Riñón / Receptores Quiméricos de Antígenos / Trastornos Linfoproliferativos Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Revista: Hum Vaccin Immunother Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos